+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development, Biopharma Production, Research, Diagnostics), End User (Biotech, CROs) - Global Forecast to 2027

  • PDF Icon

    Report

  • 237 Pages
  • November 2022
  • Region: Global
  • Markets and Markets
  • ID: 5281093

The global recombinant proteins market is projected to reach USD 2.4 billion by 2027 from USD 1.4 billion in 2022, at a CAGR of 11.4% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies and academic research institutes alongside the high prevalence of chronic and infectious diseases resulting in the need for recombinant proteins for crucial diagnostics. However, flocking to the market with competitively priced products and labor-intensive processes with low yields of recombinant protein may restrict market growth to a certain extent

The pharmaceutical & biopharmaceutical companies segment is expected to dominate the market during the forecast period.

Based on end users, the recombinant proteins market is segmented into pharmaceutical & biopharmaceutical companies, biotechnology companies, academic research institutes, contract research organizations, and other end users. Pharmaceutical & biopharmaceutical companies accounted for the largest share of the end user market in 2020. The large share of this segment is attributed to the role of recombinant proteins as a crucial component of most small molecule drug discovery programs, as well as the requirement of recombinant protein in drug discovery for the screening of the structural and mechanistic studies of new drug applications. Also, factors such as the patent expiration of blockbuster drugs impact the market growth positively.

The vaccine segment will witness the second-highest growth in the recombinant proteins market during the forecast period.

Based on type, the drug discovery & development market is segmented into biologics, vaccines, and cell & gene therapy. Vaccines accounted for the second-largest share of the drug discovery & development application for the recombinant proteins market and are expected to register the second-highest CAGR during the forecast period. The large share of the vaccine segment is attributed to factors such as increased incidence of diseases such as influenza, viral diseases and hepatitis. The emergence of such diseases has led to increased R&D activities to discover proactive vaccines and this is fueling the market growth for recombinant protein.

North America will dominate the market during the forecast period.

Geographically, the recombinant proteins market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the recombinant proteins market. The large share of this region in the global market is attributed to the rising prevalence of infectious diseases and chronic conditions, growing R&D spending by the government and pharmaceutical industry, increasing research activities by biotechnology firms, and the presence of key market players.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1: 36%, Tier 2: 45%, and Tier 3: 19%
  • By Designation - C-level: 33%, D-level: 40%, and Others: 27%
  • By Region - North America: 36%, Europe: 28%, Asia Pacific: 19%, Latin America: 10%, and Middle East and Africa 7%.

List of Companies Profiled in the Report 

  • Thermo Fisher Scientific Inc. (US) 
  • Miltenyi Biotech (Germany) 
  • Sino Biological Inc. (China) 
  • Merck KGaA (Germany)
  • Abcam plc (UK)
  • Biolegend (US)
  • Bio-Rad Laboratories, Inc. (US)
  • GenScript Biotech Corporation (China) 
  • Enzo Life Sciences, Inc. (US)
  • BPS Bioscience, Inc. (US)
  • Proteintech Group, Inc. (US)
  • Abnova Corporation (Taiwan)
  • R&D Systems (US)
  • STEMCELL Technologies Inc (Canada)
  • RayBiotech Inc (US)
  • CellGenix GmbH (Germany)
  • ACROBiosystems (US)
  • ProSpec-TechnoGene Ltd. (Israel)
  • Neuromics (US)
  • Lauraus Bio (India)
  • Icosagen AS (US)
  • ProteoGenix (France)
  • United States Biological (US)
  • StressMarq Biosciences Inc (Canada)
  • Aviva Systems Biology Corporation (US)

Research Coverage:

This report provides a detailed picture of the global recombinant proteins market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end-user, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total recombinant proteins market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report: 

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on recombinant proteins offered by the top 25 players in the recombinant proteins market. The report analyses the recombinant proteins market by product, application, end-user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various recombinant proteins across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the recombinant proteins market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the recombinant proteins market.
Frequently Asked Questions about the Global Recombinant Proteins Market

What is the estimated value of the Global Recombinant Proteins Market?

The Global Recombinant Proteins Market was estimated to be valued at $1.4 Billion in 2022.

What is the growth rate of the Global Recombinant Proteins Market?

The growth rate of the Global Recombinant Proteins Market is 11.4%, with an estimated value of $2.4 Billion by 2027.

What is the forecasted size of the Global Recombinant Proteins Market?

The Global Recombinant Proteins Market is estimated to be worth $2.4 Billion by 2027.

Who are the key companies in the Global Recombinant Proteins Market?

Key companies in the Global Recombinant Proteins Market include Abcam plc, Abnova Corporation, Acrobiosystems, Aviva Systems Biology Corporation, Bio, Rad Laboratories, Inc., Bio, Techne Corporation and BPS Bioscience, Inc..

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions and Exclusions
1.3 Market Scope
Figure 1 Recombinant Proteins Market
1.4 Years Considered
1.5 Currency Considered
1.6 Limitations
1.7 Stakeholders
1.8 Summary of Changes

2 Research Methodology
2.1 Research Data
Figure 2 Research Design
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
Figure 4 Market Size Estimation: Bottom-Up Approach
2.2.2 Top-Down Approach
Figure 5 Market Size Estimation: Top-Down Approach
2.2.3 Growth Forecast
2.3 Market Breakdown and Data Triangulation
Figure 6 Data Triangulation Methodology
2.4 Assumptions

3 Executive Summary
Figure 7 Recombinant Proteins Market, by Product, 2022 Vs. 2027 (USD Million)
Figure 8 Recombinant Proteins Market, by Application, 2022 Vs. 2027 (USD Million)
Figure 9 Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2022-2027 (USD Million)
Figure 10 Recombinant Proteins Market, by End-user, 2022 Vs. 2027 (USD Million)

4 Premium Insights
4.1 Recombinant Proteins Market Overview
Figure 12 Increasing Government Investments and Rising Focus on Personalized Medicine to Drive Market Growth
4.2 Asia-Pacific: Recombinant Proteins Market, by Application and Country (2022)
Figure 13 Drug Discovery and Development Segment to Account for Largest Share in Asia-Pacific Market
4.3 Recombinant Proteins Market, by End-user, 2022-2027
Figure 14 Pharmaceutical and Biopharmaceutical Companies to Form Largest End-User Segment for Recombinant Proteins
4.4 Recombinant Proteins Market: Geographic Snapshot
Figure 15 Japan to Register Highest Growth During Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 16 Recombinant Proteins Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 Rising Government Funding and Increasing R&D Expenditure in Pharmaceutical and Biotechnology Companies
Table 1 Government Funding for Life Science Research (2022)
5.2.1.2 High Prevalence of Infectious and Chronic Diseases
5.2.1.3 Growing Industry-Academia Collaborations
5.2.1.4 Patent Expiry of Biologics
5.2.2 Restraints
5.2.2.1 Declining Cost of Recombinant Proteins
5.2.2.2 Stringent Regulatory Scenario
5.2.3 Opportunities
5.2.3.1 Emerging Economies
5.2.3.2 Rising Focus on Personalized Medicine and Protein Therapeutics
Table 2 Commercialized Recombinant Proteins Used in Medicine
5.2.3.3 Increasing Focus on Biomarker Discovery
5.2.4 Challenges
5.2.4.1 Complications in Large-Scale Production
5.3 Pricing Analysis
5.3.1 Average Selling Price of Products, by Key Player
Table 3 Price of Recombinant Proteins, by Key Player (USD)
5.3.2 Average Selling Price Trend
Table 4 Price of Recombinant Proteins: Industrial Vs. Pharmaceutical
5.4 Stakeholder Analysis
Figure 17 Recombinant Proteins Market: Stakeholder Analysis
5.5 Value Chain Analysis
Figure 18 Value Chain Analysis: Major Value Added During Manufacturing and Assembly Phases
5.6 Ecosystem Analysis
Figure 19 Biotechnology Ecosystem Analysis: Recombinant Proteins Form an Integral Part of Biotechnology
5.7 Regulatory Analysis
5.7.1 Regulatory Bodies, Government Agencies, and Other Organizations
Table 5 North America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 6 Europe: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 7 Asia-Pacific: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 8 Rest of the World: List of Regulatory Bodies, Government Agencies, and Other Organizations
5.8 Porter's Five Forces Analysis
Table 9 Recombinant Proteins Market: Porter's Five Forces Analysis
5.8.1 Threat of New Entrants
5.8.2 Threat of Substitutes
5.8.3 Bargaining Power of Buyers
5.8.4 Bargaining Power of Suppliers
5.8.5 Intensity of Rivalry
5.9 Technology Analysis
5.10 Patent Analysis
Figure 20 Top Applicants and Owners (Companies/Institutions) for Recombinant Protein Patents (January 2012-October 2022)
Table 10 Indicative List of Patents in the Recombinant Proteins Market
5.11 Key Conferences and Events in 2022-2023
Table 11 Recombinant Proteins Market: List of Conferences and Events
5.12 Key Stakeholders and Buying Criteria
Figure 21 Influence of Stakeholders in Buying Process of Recombinant Protein Products
5.13 Key Buying Criteria of End-users
Figure 22 Buying Criteria of End-users for Recombinant Proteins

6 Recombinant Proteins Market, by Product
6.1 Introduction
6.2 Growth Factors and Chemokines
6.2.1 Growth Factors and Chemokines Accounted for Largest Market Share in 2021
Table 13 Growth Factors and Chemokines Market, by Region, 2020-2027 (USD Million)
Table 14 North America: Growth Factors and Chemokines Market, by Country, 2020-2027 (USD Million)
Table 15 Europe: Growth Factors and Chemokines Market, by Country, 2020-2027 (USD Million)
Table 16 Asia-Pacific: Growth Factors and Chemokines Market, by Country, 2020-2027 (USD Million)
6.3 Immune Response Proteins
6.3.1 Immune Checkpoint Proteins Play Key Role in Cancer Immunotherapy
Table 17 Immune Response Proteins Market, by Region, 2020-2027 (USD Million)
Table 18 North America: Immune Response Proteins Market, by Country, 2020-2027 (USD Million)
Table 19 Europe: Immune Response Proteins Market, by Country, 2020-2027 (USD Million)
Table 20 Asia-Pacific: Immune Response Proteins Market, by Country, 2020-2027 (USD Million)
6.4 Structural Proteins
6.4.1 Structural Proteins Utilized in Cell Culture Applications as Attachment Factors
Table 21 Structural Proteins Market, by Region, 2020-2027 (USD Million)
Table 22 North America: Structural Proteins Market, by Country, 2020-2027 (USD Million)
Table 23 Europe: Structural Proteins Market, by Country, 2020-2027 (USD Million)
Table 24 Asia-Pacific: Structural Proteins Market, by Country, 2020-2027 (USD Million)
6.5 Membrane Proteins
6.5.1 Membrane Proteins Regulate Processes That Help Biological Cells Survive
Table 25 Membrane Proteins Market, by Region, 2020-2027 (USD Million)
Table 26 North America: Membrane Proteins Market, by Country, 2020-2027 (USD Million)
Table 27 Europe: Membrane Proteins Market, by Country, 2020-2027 (USD Million)
Table 28 Asia-Pacific: Membrane Proteins Market, by Country, 2020-2027 (USD Million)
6.6 Kinase Proteins
6.6.1 Kinase Proteins Play Key Role in Signal Transduction Pathways
Table 29 Kinase Proteins Market, by Region, 2020-2027 (USD Million)
Table 30 North America: Kinase Proteins Market, by Country, 2020-2027 (USD Million)
Table 31 Europe: Kinase Proteins Market, by Country, 2020-2027 (USD Million)
Table 32 Asia-Pacific: Kinase Proteins Market, by Country, 2020-2027 (USD Million)
6.7 Regulatory Proteins
6.7.1 Regulatory Proteins Help Understand Cell Cycle Regulation and Carcinogenesis
Table 33 Regulatory Proteins Market, by Region, 2020-2027 (USD Million)
Table 34 North America: Regulatory Proteins Market, by Country, 2020-2027 (USD Million)
Table 35 Europe: Regulatory Proteins Market, by Country, 2020-2027 (USD Million)
Table 36 Asia-Pacific: Regulatory Proteins Market, by Country, 2020-2027 (USD Million)
6.8 Recombinant Metabolic Enzymes
6.8.1 Enzymes Regulate Protein Interactions
Table 37 Recombinant Metabolic Enzymes Market, by Region, 2020-2027 (USD Million)
Table 38 North America: Recombinant Metabolic Enzymes Market, by Country, 2020-2027 (USD Million)
Table 39 Europe: Recombinant Metabolic Enzymes Market, by Country, 2020-2027 (USD Million)
Table 40 Asia-Pacific: Recombinant Metabolic Enzymes Market, by Country, 2020-2027 (USD Million)
6.9 Adhesion Molecules and Receptors
6.9.1 Cell Adhesion Molecules Facilitate Extracellular Matrix (Ecm) Interactions
Table 41 Adhesion Molecules and Receptors Market, by Region, 2020-2027 (USD Million)
Table 42 North America: Adhesion Molecules and Receptors Market, by Country, 2020-2027 (USD Million)
Table 43 Europe: Adhesion Molecules and Receptors Market, by Country, 2020-2027 (USD Million)
Table 44 Asia-Pacific: Adhesion Molecules and Receptors Market, by Country, 2020-2027 (USD Million)
6.10 Other Recombinant Proteins
Table 45 Other Recombinant Proteins Market, by Region, 2020-2027 (USD Million)
Table 46 North America: Other Recombinant Proteins Market, by Country, 2020-2027 (USD Million)
Table 47 Europe: Other Recombinant Proteins Market, by Country, 2020-2027 (USD Million)
Table 48 Asia-Pacific: Other Recombinant Proteins Market, by Country, 2020-2027 (USD Million)

7 Recombinant Proteins Market, by Application
7.1 Introduction
Table 49 Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
7.2 Drug Discovery and Development
Table 50 Recombinant Proteins Market for Drug Discovery and Development, by Region, 2020-2027 (USD Million)
Table 51 North America: Recombinant Proteins Market for Drug Discovery and Development, by Country, 2020-2027 (USD Million)
Table 52 Europe: Recombinant Proteins Market for Drug Discovery and Development, by Country, 2020-2027 (USD Million)
Table 53 Asia-Pacific: Recombinant Proteins Market for Drug Discovery and Development, by Country, 2020-2027 (USD Million)
Table 54 Recombinant Proteins Market for Drug Discovery and Development, by Type, 2020-2027 (USD Million)
7.2.1 Biologics
7.2.1.1 Biologics are Used to Treat Cancer, Autoimmune Diseases, and Other Serious Disorders
Table 55 Recombinant Protein Biologic Drugs
Table 56 Recombinant Proteins Market for Biologics, by Region, 2020-2027 (USD Million)
Table 57 North America: Recombinant Proteins Market for Biologics, by Country, 2020-2027 (USD Million)
Table 58 Europe: Recombinant Proteins Market for Biologics, by Country, 2020-2027 (USD Million)
Table 59 Asia-Pacific: Recombinant Proteins Market for Biologics, by Country, 2020-2027 (USD Million)
7.2.2 Vaccines
7.2.2.1 Rising Incidence of Infectious Diseases to Boost Market Growth for Vaccines
Table 60 Recombinant Proteins Market for Vaccines, by Region, 2020-2027 (USD Million)
Table 61 North America: Recombinant Proteins Market for Vaccines, by Country, 2020-2027 (USD Million)
Table 62 Europe: Recombinant Proteins Market for Vaccines, by Country, 2020-2027 (USD Million)
Table 63 Asia-Pacific: Recombinant Proteins Market for Vaccines, by Country, 2020-2027 (USD Million)
7.2.3 Cell and Gene Therapy
7.2.3.1 Stem Cell Therapy and Car T-Cell Therapies Have Boosted Demand for Recombinant Proteins
Table 64 Recombinant Proteins Market for Cell and Gene Therapy, by Region, 2020-2027 (USD Million)
Table 65 North America: Recombinant Proteins Market for Cell and Gene Therapy, by Country, 2020-2027 (USD Million)
Table 66 Europe: Recombinant Proteins Market for Cell and Gene Therapy, by Country, 2020-2027 (USD Million)
Table 67 Asia-Pacific: Recombinant Proteins Market for Cell and Gene Therapy, by Country, 2020-2027 (USD Million)
7.3 Academic Research Studies
7.3.1 Recombinant Proteins Have Applications in Molecular and Gene Expression Studies
Table 68 Recombinant Proteins Market for Academic Research Studies, by Region, 2020-2027 (USD Million)
Table 69 North America: Recombinant Proteins Market for Academic Research Studies, by Country, 2020-2027 (USD Million)
Table 70 Europe: Recombinant Proteins Market for Academic Research Studies, by Country, 2020-2027 (USD Million)
Table 71 Asia-Pacific: Recombinant Proteins Market for Academic Research Studies, by Country, 2020-2027 (USD Million)
7.4 Biopharmaceutical Production
7.4.1 Recombinant Proteins Widely Used for Development of Protein-Based Drugs
Table 72 Recombinant Proteins Market for Biopharmaceutical Production, by Region, 2020-2027 (USD Million)
Table 73 North America: Recombinant Proteins Market for Biopharmaceutical Production, by Country, 2020-2027 (USD Million)
Table 74 Europe: Recombinant Proteins Market for Biopharmaceutical Production, by Country, 2020-2027 (USD Million)
Table 75 Asia-Pacific: Recombinant Proteins Market for Biopharmaceutical Production, by Country, 2020-2027 (USD Million)
7.5 Biotechnology Research
7.5.1 Increasing Number of Research Projects in Genomics to Drive Market Growth
Table 76 Recombinant Proteins Market for Biotechnology Research, by Region, 2020-2027 (USD Million)
Table 77 North America: Recombinant Proteins Market for Biotechnology Research, by Country, 2020-2027 (USD Million)
Table 78 Europe: Recombinant Proteins Market for Biotechnology Research, by Country, 2020-2027 (USD Million)
Table 79 Asia-Pacific: Recombinant Proteins Market for Biotechnology Research, by Country, 2020-2027 (USD Million)
7.6 Diagnostics
7.6.1 High Sensitivity and Specificity of Recombinant Protein-Based Diagnostics to Influence Market Growth
Table 80 Recombinant Proteins Market for Diagnostics, by Region, 2020-2027 (USD Million)
Table 81 North America: Recombinant Proteins Market for Diagnostics, by Country, 2020-2027 (USD Million)
Table 82 Europe: Recombinant Proteins Market for Diagnostics, by Country, 2020-2027 (USD Million)
Table 83 Asia-Pacific: Recombinant Proteins Market for Diagnostics, by Country, 2020-2027 (USD Million)
7.7 Other Applications
Table 84 Recombinant Proteins Market for Other Applications, by Region, 2020-2027 (USD Million)
Table 85 North America: Recombinant Proteins Market for Other Applications, by Country, 2020-2027 (USD Million)
Table 86 Europe: Recombinant Proteins Market for Other Applications, by Country, 2020-2027 (USD Million)
Table 87 Asia-Pacific: Recombinant Proteins Market for Other Applications, by Country, 2020-2027 (USD Million)

8 Recombinant Proteins Market, by End-user
8.1 Introduction
Table 88 Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
8.2 Pharmaceutical and Biopharmaceutical Companies
8.2.1 Pharmaceutical and Biopharmaceutical Companies are Largest End-users of Recombinant Proteins
Table 89 Recombinant Proteins Market for Pharmaceutical and Biopharmaceutical Companies, by Region, 2020-2027 (USD Million)
Table 90 North America: Recombinant Proteins Market for Pharmaceutical and Biopharmaceutical Companies, by Country, 2020-2027 (USD Million)
Table 91 Europe: Recombinant Proteins Market for Pharmaceutical and Biopharmaceutical Companies, by Country, 2020-2027 (USD Million)
Table 92 Asia-Pacific: Recombinant Proteins Market for Pharmaceutical and Biopharmaceutical Companies, by Country, 2020-2027 (USD Million)
8.3 Biotechnology Companies
8.3.1 Increasing Number of Projects for Protein-Based Research Driving Market Growth
Table 93 Recombinant Proteins Market for Biotechnology Companies, by Region, 2020-2027 (USD Million)
Table 94 North America: Recombinant Proteins Market for Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 95 Europe: Recombinant Proteins Market for Biotechnology Companies, by Country, 2020-2027 (USD Million)
Table 96 Asia-Pacific: Recombinant Proteins Market for Biotechnology Companies, by Country, 2020-2027 (USD Million)
8.4 Academic Research Institutes
8.4.1 Growing Government Investments to Propel Market Growth
Table 97 Recombinant Proteins Market for Academic Research Institutes, by Region, 2020-2027 (USD Million)
Table 98 North America: Recombinant Proteins Market for Academic Research Institutes, by Country, 2020-2027 (USD Million)
Table 99 Europe: Recombinant Proteins Market for Academic Research Institutes, by Country, 2020-2027 (USD Million)
Table 100 Asia-Pacific: Recombinant Proteins Market for Academic Research Institutes, by Country, 2020-2027 (USD Million)
8.5 Contract Research Organizations
8.5.1 Increasing Outsourcing of Services to Cros Driving Market Growth
Table 101 Recombinant Proteins Market for Contract Research Organizations, by Region, 2020-2027 (USD Million)
Table 102 North America: Recombinant Proteins Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
Table 103 Europe: Recombinant Proteins Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
Table 104 Asia-Pacific: Recombinant Proteins Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
8.6 Other End-users
Table 105 Recombinant Proteins Market for Other End-users, by Region, 2020-2027 (USD Million)
Table 106 North America: Recombinant Proteins Market for Other End-users, by Country, 2020-2027 (USD Million)
Table 107 Europe: Recombinant Proteins Market for Other End-users, by Country, 2020-2027 (USD Million)
Table 108 Asia-Pacific: Recombinant Proteins Market for Other End-users, by Country, 2020-2027 (USD Million)

9 Recombinant Proteins Market, by Region
9.1 Introduction
Table 109 Recombinant Proteins Market, by Region, 2020-2027 (USD Million)
9.2 North America
Figure 23 North America: Recombinant Proteins Market Snapshot
Table 110 North America: Recombinant Proteins Market, by Country, 2020-2027 (USD Million)
Table 111 North America: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 112 North America: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 114 North America: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.2.1 US
9.2.1.1 Us Accounted for Largest Share of North American Market
Table 115 Us Nih Budget for Various Disciplines, Fy 2020 Vs. Fy 2021 (USD Billion)
Table 116 US: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 117 US: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 118 US: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 119 US: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.2.2 Canada
9.2.2.1 High Prevalence of Cancer and Favorable Funding Scenario to Support Market Growth
Table 120 Canada: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 121 Canada: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 122 Canada: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 123 Canada: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.3 Europe
Table 124 Europe: Recombinant Proteins Market, by Country, 2020-2027 (USD Million)
Table 125 Europe: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 126 Europe: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 127 Europe: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 128 Europe: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.3.1 Germany
9.3.1.1 Germany Held Largest Share of European Market in 2021
Table 129 Germany: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 130 Germany: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 131 Germany: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 132 Germany: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.3.2 UK
9.3.2.1 Government Initiatives to Drive Market Growth in UK
Table 133 UK: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 134 UK: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 135 UK: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 136 UK: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.3.3 France
9.3.3.1 Infrastructural Development and Rising Life Science R&D Expected to Support Market Growth
Table 137 France: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 138 France: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 139 France: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 140 France: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.3.4 Italy
9.3.4.1 Life Science Research Investments and Favorable Funding Scenario to Drive Growth
Table 141 Italy: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 142 Italy: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 143 Italy: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 144 Italy: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.3.5 Spain
9.3.5.1 Favorable Scenario for Research Initiatives to Propel Market Growth
Table 145 Spain: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 146 Spain: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 147 Spain: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 148 Spain: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.3.6 Rest of Europe
Table 149 Roe: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 150 Roe: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 151 Roe: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 152 Roe: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.4 Asia-Pacific
Table 153 Asia-Pacific: Recombinant Proteins Market, by Country, 2020-2027 (USD Million)
Table 154 Asia-Pacific: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 155 Asia-Pacific: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 156 Asia-Pacific: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 157 Asia-Pacific: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.4.1 Japan
9.4.1.1 Advanced Healthcare Infrastructure to Support Market Growth
Table 158 Japan: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 159 Japan: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 160 Japan: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 161 Japan: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.4.2 China
9.4.2.1 China to Witness Highest Growth in Asia-Pacific Market
Table 162 China: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 163 China: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 164 China: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 165 China: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.4.3 India
9.4.3.1 Strong Biopharmaceutical Growth and Rising Demand for Pharmaceuticals are Key Market Drivers
Table 166 India: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 167 India: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 168 India: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 169 India: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.4.4 Rest of Asia-Pacific
Table 170 Roapac: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 171 Roapac: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 172 Roapac: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 173 Roapac: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.5 Latin America
9.5.1 Growth in Biopharmaceutical Industry to Drive Demand for Recombinant Proteins
Table 174 Latin America: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 175 Latin America: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 176 Latin America: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 177 Latin America: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
9.6 Middle East & Africa
9.6.1 Increasing Government Investments in Healthcare Sector and Growing Pharmaceutical Industry to Support Market Growth
Table 178 Middle East & Africa: Recombinant Proteins Market, by Product, 2020-2027 (USD Million)
Table 179 Middle East & Africa: Recombinant Proteins Market, by Application, 2020-2027 (USD Million)
Table 180 Middle East & Africa: Recombinant Proteins Market for Drug Discovery and Development Applications, by Type, 2020-2027 (USD Million)
Table 181 Middle East & Africa: Recombinant Proteins Market, by End-user, 2020-2027 (USD Million)
10 Competitive Landscape
10.1 Overview
Figure 25 Key Players Adopted Organic and Inorganic Growth Strategies Between 2019 and 2022
10.2 Market Share Analysis
Figure 26 Recombinant Proteins Market: Market Share Analysis, 2021 (Top 4 Players)
Table 182 Recombinant Proteins Market: Degree of Competition
10.3 Revenue Share Analysis of Top Market Players
Figure 27 Revenue Share Analysis of Players in Recombinant Proteins Market (Top 4)
10.4 Company Evaluation Matrix: Key Players (2021)
10.4.1 Vendor Inclusion Criteria
10.4.2 Stars
10.4.3 Emerging Leaders
10.4.4 Pervasive Players
10.4.5 Participants
Figure 28 Recombinant Proteins Market: Company Evaluation Matrix for Key Players (2021)
10.5 Company Evaluation Matrix: Start-Ups/Smes (2021)
10.5.1 Progressive Companies
10.5.2 Starting Blocks
10.5.3 Responsive Companies
10.5.4 Dynamic Companies
Figure 29 Recombinant Proteins Market: Company Evaluation Matrix for Start-Ups/Smes (2021)
10.6 Competitive Benchmarking of Top 25 Companies
10.6.1 Overall Footprint of Top 25 Companies
Figure 30 Footprint Analysis of Key Players in Recombinant Proteins Market
10.7 Competitive Benchmarking of Key Start-Ups/Smes
Table 183 Recombinant Proteins Market: Detailed List of Key Start-Ups/SMEs
Table 184 Recombinant Proteins Market: Competitive Benchmarking of Key Start-Ups/SMEs
10.8 Competitive Scenario
10.8.1 Product Launches and Approvals (2019-2022)
10.8.2 Deals (2019-2022)
10.8.3 Expansions (2019-2022)
11 Company Profiles
11.1 Key Players
(Business Overview, Products/Services/Solutions Offered, Analyst's View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 Bio-Techne Corporation
Table 185 R&D Systems: Business Overview
Figure 31 Bio-Techne Corporation: Company Snapshot (2021)
11.1.2 Thermo Fisher Scientific, Inc.
Table 186 Thermo Fisher Scientific, Inc.: Business Overview
Figure 32 Thermo Fisher Scientific, Inc.: Company Snapshot (2021)
11.1.3 Merck KGaA
Table 187 Merck KGaA: Business Overview
Figure 33 Merck KGaA: Company Snapshot (2021)
11.1.4 Abcam plc
Table 188 Abcam plc: Business Overview
Figure 34 Abcam plc: Company Snapshot (2021)
11.1.5 Abnova Corporation
Table 189 Abnova Corporation: Business Overview
11.1.6 Biolegend
Table 190 Biolegend: Business Overview
11.1.7 Bio-Rad Laboratories, Inc.
Table 191 Bio-Rad Laboratories, Inc.: Business Overview
Figure 35 Bio-Rad Laboratories, Inc.: Company Snapshot (2021)
11.1.8 Bps Bioscience, Inc.
Table 192 Bps Bioscience, Inc.: Business Overview
11.1.9 Enzo Life Sciences, Inc.
Table 193 Enzo Life Sciences, Inc.: Business Overview
Figure 36 Enzo Biochem, Inc.: Company Snapshot (2021)
11.1.10 Genscript Biotech Corporation
Figure 37 Genscript Biotech Corporation: Company Snapshot (2021)
11.1.11 Miltenyi Biotec
Table 195 Miltenyi Biotech: Business Overview
11.1.12 Proteintech Group
Table 196 Proteintech Group: Business Overview
11.1.13 Sino Biological Inc.
Table 197 Sino Biological Inc.: Business Overview
*Business Overview, Products/Services/Solutions Offered, Analyst's View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments Might Not be Captured in Case of Unlisted Companies.
11.2 Other Players
11.2.1 Acrobiosystems
11.2.2 Aviva Systems Biology Corporation
11.2.3 Cellgenix GmbH
11.2.4 Icosagen As
11.2.5 Neuromics
11.2.6 Prospec-Technogene Ltd.
11.2.7 Proteogenix
11.2.8 Raybiotech, Inc.
11.2.9 Laurus Bio (Richcore Lifesciences Pvt. Ltd.)
11.2.10 Stemcell Technologies Inc.
11.2.11 Stressmarq Biosciences Inc.
11.2.12 United States Biological

12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: The Subscription Portal
12.3 Customization Options

Executive Summary

Companies Mentioned

  • Abcam plc
  • Abnova Corporation
  • Acrobiosystems
  • Aviva Systems Biology Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biolegend
  • BPS Bioscience, Inc.
  • Cellgenix GmbH
  • Enzo Life Sciences, Inc.
  • Genscript Biotech Corporation
  • Icosagen As
  • Laurus Bio (Richcore Lifesciences Pvt. Ltd.)
  • Merck KGaA
  • Miltenyi Biotec
  • Neuromics
  • Prospec-Technogene Ltd.
  • Proteintech Group
  • Proteogenix
  • Raybiotech, Inc.
  • Sino Biological Inc.
  • Stemcell Technologies Inc.
  • Stressmarq Biosciences Inc.
  • Thermo Fisher Scientific, Inc.
  • United States Biological

Methodology

Loading
LOADING...